154 related articles for article (PubMed ID: 12232531)
1. [Fibrinogen: factor and marker of cardiovascular risk].
Drouet L; Bal Dit Sollier C
J Mal Vasc; 2002 Jun; 27(3):143-56. PubMed ID: 12232531
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
Ernst E
Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
[TBL] [Abstract][Full Text] [Related]
3. [Is fibrinogen a predictor or a marker of the risk of cardiovascular events?].
Drouet L; Bal dit Sollier C
Therapie; 2005; 60(2):125-36. PubMed ID: 15969315
[TBL] [Abstract][Full Text] [Related]
4. [Fibrinogen. Cardiovascular risk factor or marker?].
Canseco-Avila LM; Jerjes-Sánchez C; Ortiz-López R; Rojas-Martínez A; Guzmán-Ramírez D
Arch Cardiol Mex; 2006; 76 Suppl 4():S158-72. PubMed ID: 17469344
[TBL] [Abstract][Full Text] [Related]
5. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
6. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Corson MA; Jones PH; Davidson MH
Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in the "fibrinogen hypothesis"].
Lefebvre P; Ledent T; Ducobu J
Rev Med Brux; 2003 Apr; 24(2):82-7. PubMed ID: 12806874
[TBL] [Abstract][Full Text] [Related]
8. [Fibrinogen: cardiovascular risk factor].
Espinosa RA;
Invest Clin; 2002 Dec; 43(4):291-301. PubMed ID: 12521001
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
Spiel AO; Gilbert JC; Jilma B
Circulation; 2008 Mar; 117(11):1449-59. PubMed ID: 18347221
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
Jaeger BR; Labarrere CA
Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
[TBL] [Abstract][Full Text] [Related]
11. [Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
Halvorsen S
Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2829-32. PubMed ID: 10494205
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
Li JJ; Fang CH
Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
[TBL] [Abstract][Full Text] [Related]
13. [Fibrinogen--acute phase protein as a marker of immunological process as atherosclerosis].
Rajtari R; Kloch M; Kiec-Wilk B; Kolasińska-Kloch W
Folia Med Cracov; 2005; 46(1-2):21-32. PubMed ID: 17037285
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
[TBL] [Abstract][Full Text] [Related]
15. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
[TBL] [Abstract][Full Text] [Related]
16. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein: a new golden marker of cardiovascular risk.
Gomes MC
Rev Port Cardiol; 2002 Nov; 21(11):1329-46. PubMed ID: 12564084
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.
Coppola G; Corrado E; Muratori I; Tantillo R; Vitale G; Lo Coco L; Novo S
Int J Cardiol; 2006 Jan; 106(1):16-20. PubMed ID: 16321660
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
Divecha H; Sattar N; Rumley A; Cherry L; Lowe GD; Sturrock R
Clin Sci (Lond); 2005 Aug; 109(2):171-6. PubMed ID: 15801904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
